NCT04698590

Brief Summary

Aberrations are the spreading of light from a point focus. Aberrations of the eyes can be objectively evaluated with a wavefront aberrometer. Lower order aberrations such as defocus and astigmatism can be corrected with glasses and traditional/disposable soft contact lenses. Patients with ectatic corneal disease, such as keratoconus, or irregular astigmatism cause by surgery, trauma or disease, experience vision that is unlikely to be adequately corrected with glasses or disposable soft contact lenses due to higher order aberrations (HOA). HOA's cause halos, flare, glare, starbursts, doubling, smearing or ghosting of vision. Specialty contact lenses, such as scleral lenses, can be used to mask the irregularity of the cornea, reducing HOA's and improving vision. In many patients the resultant vision, though improved, still has some level of residual HOA's affecting the quality of vision. Custom scleral lenses with customized wavefront guided optics can be used to reduce residual HOA's and improve vision further. These lenses have been referred to as higher order aberration correcting scleral lenses or HOA correcting sclerals and wavefront guided scleral lenses or WFG sclerals.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 31, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 7, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

January 15, 2021

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 3, 2024

Status Verified

May 1, 2024

Enrollment Period

4 years

First QC Date

December 31, 2020

Last Update Submit

May 2, 2024

Conditions

Keywords

Scleral lensesScleral lensWavefront guided scleral lensesHigher order aberrationsHOA scleral lensesScleralsHigher order aberration correctionCustom scleral lensesWavefront guidedKeratoconusIrregular AstigmatismWFG scleral lenses

Outcome Measures

Primary Outcomes (1)

  • Higher order aberration

    Total higher order aberrations with traditional scleral lenses will be compared with wavefront guided scleral lenses for all eyes. A secondary analysis of this endpoint, the change in total higher order aberrations with wavefront guided scleral lenses from dispense to 4 week follow up, will be evaluated.

    4 weeks

Secondary Outcomes (2)

  • Visual Acuity

    4 weeks

  • Contrast Sensitivity

    4 weeks

Study Arms (2)

WFG Scleral Lenses

ACTIVE COMPARATOR

Scleral lenses with customized wavefront guided optics

Device: Wavefront Guided Scleral Lenses

Traditional Scleral Lenses

PLACEBO COMPARATOR

Scleral lenses with traditional optics

Device: Traditional Scleral Lenses

Interventions

Custom wavefront guided, higher order aberration correcting scleral lenses

Also known as: ARES Scleral Lenses
WFG Scleral Lenses

Traditional scleral lenses

Also known as: CS Scleral Lenses
Traditional Scleral Lenses

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of keratoconus or irregular astigmatism

You may not qualify if:

  • Patients with other visually significant ocular pathology.
  • Inability to apply or remove a scleral lens.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cornea and Laser Eye Institue - Hersh Vision Group

Teaneck, New Jersey, 07666, United States

Location

MeSH Terms

Conditions

KeratoconusCorneal Wavefront Aberration

Condition Hierarchy (Ancestors)

Corneal DiseasesEye DiseasesRefractive Errors

Study Officials

  • John D Gelles, OD

    The Cornea and Laser Eye Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 31, 2020

First Posted

January 7, 2021

Study Start

January 15, 2021

Primary Completion

January 31, 2025

Study Completion

December 31, 2025

Last Updated

May 3, 2024

Record last verified: 2024-05

Locations